Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,492 across all filing types
Latest filing 2025-01-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
关于2024年12月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for December 2024 from Tian Kang Biological Co., Ltd., detailing monthly and cumulative sales volumes and revenues of live pigs. It includes sales data, price trends, and risk warnings. The document is short (1741 characters), contains no comprehensive financial statements or detailed analysis, and explicitly states the data is unaudited and for reference only. It is a periodic sales update rather than a full financial report or earnings release. It does not announce voting results, management changes, or legal matters. Given the nature and length, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement providing operational data without full financial reporting or formal earnings highlights.
2025-01-08 Chinese
关于天康生物股份有限公司2024年第六次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2024 sixth extraordinary general meeting (临时股东大会) of Tian Kang Bio. It details the legality of the meeting's call, attendance qualifications, voting procedures, and the validity of the resolutions passed. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is not an announcement of voting results in a brief form but a detailed legal opinion on the meeting's legality and voting process. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to official confirmation and legal opinion on shareholder voting results at a general meeting.
2024-12-30 Chinese
2024年第六次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 sixth extraordinary general meeting of shareholders of Tian Kang Biological Co., Ltd. It includes information about the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather the official voting results and meeting details. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2254 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DVA with high confidence.
2024-12-30 Chinese
关于控股股东增持公司股份的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a controlling shareholder's plan to increase their shareholding in the company. It details the number of shares purchased, the amount spent, the financing support obtained, and the risks involved. It references previous announcements about the share increase plan and provides updated figures on the shareholding changes. There are no financial statements, earnings data, or management discussion of financial results. The document is focused on shareholding changes by a major shareholder, specifically the controlling shareholder's incremental share purchases and related financing. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is under 5,000 characters and is a detailed announcement, not a brief report publication notice or a certification. Therefore, the correct classification is MRQ with high confidence.
2024-12-25 Chinese
关于控股股东增持公司股份达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the increase in shareholding by the controlling shareholder of the company, Xinjiang Production and Construction Corps State-owned Assets Management Co., Ltd., who has increased their stake by over 1%. It details the number of shares purchased, the percentage of total shares, the funding sources, and compliance with relevant securities laws. The document includes specific dates and shareholding percentages but does not contain financial statements or detailed financial performance data. It is a notification of a major shareholding change rather than a financial report or other type of filing. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length is 3079 characters, which is consistent with a detailed announcement but not a full report.
2024-12-19 Chinese
第八届董事会第二十二次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a specific board meeting of Tian Kang Biological Co., Ltd. It details the approval of proposals related to the company's controlling subsidiary's planned public stock issuance and listing on the Beijing Stock Exchange, as well as the scheduling of a shareholders' meeting to consider these proposals. The document includes voting results and references to other related announcements but does not contain financial statements or detailed financial data. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or financial statement itself, but an official announcement of board decisions.
2024-12-12 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.